Influence of antecedent Glivec® therapy (imatinib mesylate) on allogeneic stem cell transplantation outcome in CML Ph+ and ALL Ph+ patients -: single-centre experience

被引：0
|
作者：
Holowiecki, J [1 ]
Kruzel, T [1 ]
Wojnar, J [1 ]
Krawczyk-Kulis, M [1 ]
Wylezol, I [1 ]
机构：
[1] L Warynski Silesian Med Acad, Katowice, Poland
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [31] A SINGLE-CENTRE EXPERIENCE OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS
    Routledge, D. J. M.
    Dignan, F.
    Tholouli, E.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S184 - S185
  • [32] Allogeneic stem cell transplantation for CML. A single centre experience with 125 patients.
    Brinch, L
    Egeland, T
    Tjoennfjord, G
    Gedde-Dahl, T
    Albrechtsen, D
    Evensen, SA
    BLOOD, 2002, 100 (11) : 428A - 428A
  • [33] Allogeneic stem cell transplantation in multiple myeloma: Single-centre experience of 106 patients
    Uotinen, H.
    Volin, L.
    Juvonen, E.
    Nihtinen, A.
    Ruutu, T.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S153 - S153
  • [34] MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure
    M Agrawal
    B Hanfstein
    P Erben
    D Wolf
    T Ernst
    A Fabarius
    S Saussele
    D Purkayastha
    R C Woodman
    W-K Hofmann
    R Hehlmann
    A Hochhaus
    M C Müller
    Leukemia, 2014, 28 : 1478 - 1485
  • [35] Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy
    S P Chantepie
    M Michallet
    D Blaise
    S Maury
    E Deconinck
    R Tabrizi
    N Contentin
    M Mohty
    S Nguyen
    B Lioure
    N Raus
    R Peffault de Latour
    I Yakoub-Agha
    O Reman
    Bone Marrow Transplantation, 2015, 50 : 1586 - 1588
  • [36] The impact of pretransplant imatinib use in allogeneic haematopoietic cell transplantation for CML:: a single-centre comparative analysis
    Bilgin, A. Ugur
    Soydan, E. A.
    Topcuoglu, P.
    Gunaydan, Y.
    Uysal, A.
    Konuk, N.
    Beksac, M.
    Akan, H.
    Gurman, G.
    Ozcan, M.
    Arslan, O.
    Demirer, T.
    Ilhan, O.
    Arat, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S68 - S69
  • [37] What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph+ ALL?
    Mele, Giuseppe
    Pinna, Salvatore
    Melpignano, Angela
    Romano, Antonio
    Brocca, Maurizio Claudio
    Coppi, Maria Rosaria
    Quarta, Giovanni
    LEUKEMIA RESEARCH, 2007, 31 (10) : 1445 - 1447
  • [38] Imatinib (Glivec) therapy in advanced chronic myeloid leukemia (CML) patients in combination with allogeneic peripheral blood stem cell transplantation (PBSCT).
    le Coutre, P
    Massenkeil, G
    Zschieschang, P
    Genvresse, I
    Schwarz, M
    Reich, G
    Körner, H
    Dörken, B
    Arnold, R
    BLOOD, 2002, 100 (11) : 428A - 429A
  • [39] Outcome following second allogeneic hematopoietic cell transplantation: a single-centre experience
    Aljasem, H.
    Messner, H.
    Lipton, J.
    Kim, D.
    Viswabandya, A.
    Thyagu, S.
    Deotare, U.
    Michelis, F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S302 - S303
  • [40] Thrombotic microangiopathy after allogeneic stem cell transplantation:: a single-centre experience
    Vallansot, R. O.
    Martinez, C.
    Roncero, J. M.
    Fernandez-Aviles, F.
    Abrisqueta, P.
    Gutierrez-Garcia, G.
    Rovira, M.
    Urbano-Ispizua, A.
    Montserrat, E.
    Carreras, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S88 - S88
12345